Wird geladen...
Beyond Peptides and mAbs - Current Status and Future Perspectives for Biotherapeutics with Novel Constructs
Biotherapeutics are attractive anti-cancer agents due to their high specificity and limited toxicity compared to conventional small molecules. Antibodies are widely used in cancer therapy, either directly or conjugated to a cytotoxic payload. Peptide therapies, though not as prevalent, have been uti...
Gespeichert in:
| Veröffentlicht in: | J Clin Pharmacol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4340091/ https://ncbi.nlm.nih.gov/pubmed/25707963 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.407 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|